Yngve Mikkelsen

High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway

Carola Rosseland, R. Leiva, O. Dalgard, 2022, Scandinavian journal of gastroenterology.